Abstract
The new name for Pharmaceutical Companies Analysis
Dear Subscriber,
I am taking the opportunity of your renewal notice to bring to your attention
an important development to your subscription to 4D Pharma, the pharmaceutical
corporate analysis service formally known as Pharmaceutical Companies Analysis.
BIG IMPROVEMENTS
In addition to the new name, we have been busy developing the service and its
contents. Many of the changes, which we have introduced over the past two
years will be known to you. The final development has now been completed, and
that is the inclusion of 5-year financial forecasts for significant products
in the company' s pipeline.